Induction of interleukin-15 production by HIV-1 Nef protein: A role in the proliferation of uninfected cells

Experimental Cell Research

Volumn 250, Issue 1, 1999, Pages 112-121

  Quaranta, Maria Giovanna ^a   Camponeschi, Barbara ^a   Straface, Elisabetta ^a   Malorni, Walter ^a   Viora, Marina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cell activation; HIV 1; IL 15; Nef protein

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; NEF PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0033542740     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4494     Document Type: Article

References (48)

1. McCune J. M. HIV-1: The infective process in vivo. Cell. 64:1991;351-363.
2. Arya S. K., Guo C., Josephs S. F., Wong-Staal F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science. 229:1985;69-73.
3. Cullen B. R. The role of Nef in the replication cycles of the human and simian immunodeficiency viruses. Virology. 205:1994;1-6.
4. Maitra R. K., Ahmad N., Holland S. M., Venkatesan S. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines. Virology. 182:1991;522-533.
5. Niederman T. M. J., Thielan B. J., Ratner L. Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc. Natl. Acad. Sci. USA. 86:1989;1128-1132.
6. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The Human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-113.
7. Kestler H. W. III, Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desroiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
8. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. Protective effects of a live attenuated SIV vaccine with a deletion in the Nef gene. Science. 258:1992;1938-1941.
9. Fujii Y., Otake K., Tashiro M., Adachi A. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett. 393:1996;93-96.
10. Cheingsong-Popov R., Panagiotidi C., Ali M., Bowcock S., Watkins P., Aronstam A., Wassef M., Weber J. Antibodies to HIV-1 nef (p27): Prevalence, significant and relationship to seroconversion. AIDS Res. Hum. Retrovirus. 6:1990;1099-1105.
11. Sabatier J. M., Clerget-Raslain B., Fontan G., Fenuillet E., Rochat H., Granier C., Gluckman J., Van Rietschoten J., Montagnier L., Bahraoui E. Use of synthetic peptides for detection of antibodies against the nef regulating protein in sera of HIV-infected patients. AIDS. 3:1989;215-220.
12. - T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursor at high frequency. Int. Immunol. 6:1994;1739-1749.
13. Lucchiari-Hartz M., Bauer M., Niedermann G., Maier B., Meyerhans A., Eichmann K. Human immune response to HIV-1 Nef. II. Induction of HIV-1/HIV-2 Nef cross-reactive cytotoxic T lymphocytes of non-infected healthy individuals. Int. Immunol. 8:1996;577-584.
14. Collins K. L., Chen B. K., Kalams S. A., Walker B. D., Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 391:1998;397-401.
15. Skowronski J., Parks D., Mariani R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:1993;703-713.
16. Chirmule N., Oyaizu N., Saxinger C., Pahwa S. Nef protein of HIV-1 has B-cell stimulatory activity. AIDS. 8:1994;733-739.
17. Torres B. A., Johnson M. H. Identification of an HIV-1 nef peptide that binds to HLA class II antigens. Biochem. Biophys. Res. Commun. 200:1994;1059-1065.
18. Torres B. A., Tanabe T., Johnson M. H. Replication of HIV-1 in human peripheral blood mononuclear cells activated by exogenous nef. AIDS. 10:1996;1042-1043.
19. Greenway A. L., Azad A., McPhee D. A. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69:1995;1842-1850.
20. Peters M. G., Secrist H., Anders K. R., Nash G. S., Rich S. R., MacDermott R. P. Normal human intestinal lymphocytes. Increased activation compared with the peripheral blood. J. Clin. Invest. 83:1989;1827-1833.
21. Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M., Jonhson L., Alderson M. R., Watson J. D., Anderson D. M., Giri J. G. Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor. Science. 264:1994;965-970.
22. Doherty T. M., Seder R. A., Sher A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:1996;735-741.
23. Bamford R. N., Battiata A., Burton J. D., Sharma H., Waldmannm T. Interleukin (IL)15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA. 93:1996;2897-2902.
24. Greenway A. L., McPhee D. A., Grgacic E., Hewish D., Lucantoni A., Macreadie I., Azad A. Nef 27, but not the nef 25 isoform of human immunodeficiency virus-type pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology. 198:1994;245-256.
25. Luria S., Chambers I., Berg P. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Accad. Sci. USA. 88:1991;5326-5330.
26. Collette Y., Chang H. L., Cerdan C., Chambost H., Algarte M., Mawas C., Imbert J., Burny A., Olive D. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression. J. Immunol. 156:1996;360-370.
27. Armitage R. J., Macduff B. M., Eisenman J., Paxton R., Grabstein K. H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:1995;483-487.
28. Carson W. E., Giri J. G., Lindemann M. J., Linett M. L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caliguri M. A. Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1994;1395-1401.
29. Seder R. A., Grabstein K. H., Berzofsky J. A., McDyer J. F. Cytokine interactions in human immunodeficiency virus-infected individuals: Roles of interleukin (IL)-2, IL-12 and IL-15. J. Exp. Med. 182:1995;1067-1078.
30. Carson W. E., Ross M. E., Baiocchi R. A., Marien M. J., Boiani N., Grabstein K., Caliguri M. A. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:1995;2578-2582.
31. Rouaix F., Grass-Mass H., Mazingue C., Diesis E., Ridel P. R., Estaquier J., Capron A., Tartar A., Auriault C. Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cells. Vaccine. 12:1994;1209-1214.
32. Rosemberg Z. F., Fauci A. Immunopathogenic mechanisms of HIV-infection: Cytokine induction of HIV expression. Immunol. Today. 11:1990;176-180.
33. Fauci A. S. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:1996;529-532.
34. Poli G., Fauci A. S. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. Aggarwal B. B., Puri R. K. Human Cytokines: Their Role in Disease and Therapy. 1995;421-435 Blackwell Scientific, Cambridge.
35. Swapan K., Chettemgere D., Venkateshan N. S., Seth P., Gajd-usek C., Clarence D., Gibbs J. Jr. Adenovirus-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcγ receptors and expression of monokines. Blood. 6:1998;2108-2117.
36. Poli G., Fauci A. S. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res. Hum. Retroviruses. 8:1992;191-195.
37. Kanai T., Thomas E. K., Yasutomi Y., Letvin N. L. IL-15 stimulates the expansion of AIDS virus-specific CTL. J. Immunol. 157:1996;3681-3687.
38. Fackler O. T., Kienzle N., Kremmer E., Boese A., Schramm B., Klimkait T., Kucherer C., Mueller-Lantzsch N. Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur. J. Biochem. 247:1997;843-851.
39. Fujinaga K., Zhong Q., Nakaya T., Kameoka M., Meguro T., Yamada K., Ikuta K. Extracellular Nef protein regulates productive HIV-1 infection from latency. J. Immunol. 155:1995;5289-5298.
40. Pandori M. W., Fitch N. J. S., Craig H. M., Richmann D. D., Spina C. A., Guatelli J. C. Producer-cell modification of human immunodeficiency virus type 1:Nef is a virion protein. J. Virol. 70:1996;4283-4290.
41. Welker R., Kottler H., Kalbitzer H. R., Krausslich H.-G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology. 219:1996;228-236.
42. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., MecPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crove S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
43. Peper R. J., Tina W. Z., Mickelson M. M. Purification of lymphocytes and platelets by gradient centrifugation. J. Lab. Clin. Med. 72:1968;842-846.
44. Bull D. M., Bookmann M. A. Isolation and functional characterization of human mucosal lymphoid cells. J. Clin. Invest. 59:1977;966-974.
45. Gessani S., Testa U., Varano B., Di Marzio P., Borghi P., Conti L., Barberi T., Tritarelli E., Martucci R., Seripa D., Peschle C., Belardelli F. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages: Role of LPS-receptors. J. Immunol. 151:1993;1-9.
46. Chomczynsky P., Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
47. Viora M., Camponeschi B. Down-regulation of interleukin-2 receptor gene activation and protein expression by dideoxynucleoside analogs. Cell. Immunol. 163:1995;289-295.
48. Haraguchi S., Good R. A., James-Yarish M., Cianciolo G. J. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. USA. 92:1995;3611-3615.